(Q41153046)

English

Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease

scientific article published on November 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 September 2017

Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease (English)

1 reference

Europe PubMed Central

27 September 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

ipratropium bromide

1 reference

based on heuristic

inferred from title

author name string

Newnham DM

1

1 reference

Europe PubMed Central

27 September 2017

Dhillon DP

2

1 reference

Europe PubMed Central

27 September 2017

Winter JH

3

1 reference

Europe PubMed Central

27 September 2017

Jackson CM

4

1 reference

Europe PubMed Central

27 September 2017

Clark RA

5

1 reference

Europe PubMed Central

27 September 2017

Lipworth BJ

6

1 reference

Europe PubMed Central

27 September 2017

language of work or name

0 references

publication date

1 November 1993

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

48

1 reference

Europe PubMed Central

27 September 2017

11

1 reference

Europe PubMed Central

27 September 2017

1151-1155

1 reference

Europe PubMed Central

27 September 2017

Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

27 September 2017

Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

27 September 2017

Statistics on microcomputers. A non-algebraic guide to their appropriate use in biomedical research and pathology practice. 3. Analysis of variance and distribution-free methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

27 September 2017

Dose response relation to oral theophylline in severe chronic obstructive airways disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

27 September 2017

Muscarinic receptor subtypes: implications for lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

27 September 2017

Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

27 September 2017

Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

27 September 2017

Bronchodilatation and the site of airway resistance in severe chronic bronchitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

27 September 2017

Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

27 September 2017

Errors in the measurement of vital capacity: A comparison of three methods in normal subjects and in patients with pulmonary emphysema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

27 September 2017

Beta-adrenoceptor responses to inhaled salbutamol in the elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

14 June 2018

Comparison of the effects of prolonged treatment with low and high doses of inhaled terbutaline on beta-adrenoceptor responsiveness in patients with chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

14 June 2018

The effects of salbutamol aerosol on lung function in patients with pulmonary emphysema.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

19 August 2018

Influence of age on response to ipratropium and salbutamol in asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=464905

19 August 2018

Comparative Trial of a New Anticholinergic Bronchodilator, Sch 1000, and Salbutamol in Chronic Bronchitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8296260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8296260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of bronchodilation in the clinical pulmonary function laboratory. Role of changes in static lung volumes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8296260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of nebulized salbutamol on lung function and exercise tolerance in patients with severe airflow obstruction

1 reference

https://pubmed.ncbi.nlm.nih.gov/8296260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence

1 reference

https://pubmed.ncbi.nlm.nih.gov/8296260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8296260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nebuhaler technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/8296260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cumulative dose-response curves for assessing combined effects of salbutamol and ipratropium bromide in chronic asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8296260

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/THX.48.11.1151

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

1 reference

Europe PubMed Central

27 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41153046&oldid=1916030084"